An amazing conference!

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

Read about our conference in Bucharest: our new song "North Star - HD8890", predictive testing, sexuality and ongoing drug development.

Conference Presentations

Some of the presentations presented during our conference are now available in pdf! Find them here.

Some of the presentations presented during our conference are now available in pdf! Find them here.

Some of the presentations presented during our conference are now available in pdf! Find them here.

October 3, the European HD-COPE members and the EHA board met to talk about patient advocacy and latest Huntington news.

October 3, the European HD-COPE members and the EHA board met to talk about patient advocacy and latest Huntington news.

October 3, the European HD-COPE members and the EHA board met to talk about patient advocacy and latest Huntington news.

Update on GENERATION HD1 study

The enrolment in the the Phase III trial GENERATION HD1 study has been increased from 660 to 801 participants worldwide!

The enrolment in the the Phase III trial GENERATION HD1 study has been increased from 660 to 801 participants worldwide!

The enrolment in the the Phase III trial GENERATION HD1 study has been increased from 660 to 801 participants worldwide!

previous arrowprevious arrow
next arrownext arrow
Slider

NEWS


EHA19: An Amazing Conference

October 4-6, the European Huntington Association conference was held in Bucharest. 220 professionals and family members were gathered in Romania to meet others and to ...
Read More

HD-COPE: Meeting with European patient representatives

Thursday afternoon, October 3, the European HD-COPE members and the European Huntington Association board met in Bucharest, Romania. They talked about patient advocacy and latest ...
Read More

Update on GENERATION HD1 study

The enrolment in the Phase III GENERATION HD1 study has been increased from 660 to 801 participants worldwide.This change does not impact participants already enrolled ...
Read More

CONTACT US